PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
3.16%
Revenue growth of 3.16% while MCHP is flat. Bruce Berkowitz would check if a small edge can widen further.
7.64%
Gross profit growth of 7.64% while MCHP is zero. Bruce Berkowitz would see if minimal improvements could expand further.
-97.12%
Negative EBIT growth while MCHP is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-97.12%
Negative operating income growth while MCHP is at 0.00%. Joel Greenblatt would press for urgent turnaround measures.
0.75%
Net income growth of 0.75% while MCHP is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
-7.69%
Negative EPS growth while MCHP is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
No Data
No Data available this quarter, please select a different quarter.
26.80%
Share change of 26.80% while MCHP is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
-7.31%
Reduced diluted shares while MCHP is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-21.13%
Dividend reduction while MCHP stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
19.36%
OCF growth of 19.36% while MCHP is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
62.50%
FCF growth of 62.50% while MCHP is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
77.23%
10Y CAGR of 77.23% while MCHP is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
35.62%
5Y CAGR of 35.62% while MCHP is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
28.40%
3Y CAGR of 28.40% while MCHP is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
627.81%
3Y OCF/share CAGR of 627.81% while MCHP is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
954.25%
10Y net income/share CAGR of 954.25% while MCHP is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
40.07%
Net income/share CAGR of 40.07% while MCHP is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
314.28%
3Y net income/share CAGR of 314.28% while MCHP is zero. Bruce Berkowitz sees if minor improvements can widen to a bigger advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-6.17%
Negative 3Y equity/share growth while MCHP is at 0.00%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
3.56%
Dividend/share CAGR of 3.56% while MCHP is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
-41.28%
Negative near-term dividend growth while MCHP invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
10.84%
AR growth of 10.84% while MCHP is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
2.55%
Inventory growth of 2.55% while MCHP is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
7.36%
Asset growth of 7.36% while MCHP is zero. Bruce Berkowitz checks if modest expansions can create a longer-term lead.
-15.41%
We have a declining book value while MCHP shows 0.00%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
1.99%
Debt growth of 1.99% while MCHP is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
No Data
No Data available this quarter, please select a different quarter.
8.63%
SG&A growth of 8.63% while MCHP is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.